A5013131907- Peripheral Artery Disease Management
- Coronary Interventions and Diagnostics
- Vascular Procedures and Complications
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Venous Thromboembolism Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Mechanical Circulatory Support Devices
- Cerebrovascular and Carotid Artery Diseases
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- COVID-19 and healthcare impacts
- Infective Endocarditis Diagnosis and Management
- COVID-19 Clinical Research Studies
- Renal and Vascular Pathologies
- Cardiovascular Disease and Adiposity
- Cardiovascular Function and Risk Factors
- Acute Ischemic Stroke Management
- Acute Kidney Injury Research
- Cardiovascular and Diving-Related Complications
- Heart Failure Treatment and Management
- Aortic aneurysm repair treatments
- Diabetic Foot Ulcer Assessment and Management
Tulane University
2023-2025
Montefiore Medical Center
2016-2024
Albert Einstein College of Medicine
2016-2024
Mount Sinai Medical Center
2011-2024
Tulane Medical Center
2023
Montefiore Health System
2022
Henry Ford Health System
2021
John Wiley & Sons (United States)
2020
University of Puerto Rico System
2019
Massachusetts General Hospital
2018
Background— Prior studies have reported higher inhospital mortality in women versus men with non–ST-segment–elevation myocardial infarction. Whether this is because of worse baseline risk profile compared or sex-based disparities treatment not completely understood. Methods and Results— We queried the 2003 to 2014 National Inpatient Sample databases identify all hospitalizations patients aged ≥18 years principal diagnosis Complex samples multivariable logistic regression models were used...
To investigate the impact on restenosis rates of deep injury to adventitial layer during directional atherectomy.Between 2007 and 2010, 116 consecutive patients (mean age 69.6 years; 56 men) with symptomatic femoropopliteal stenoses were treated atherectomy at a single center. All had claudication TASC A/B lesions in superficial femoral or popliteal arteries. Histopathology analysis specimens was performed identify injury. Clinical follow-up included physical examination duplex ultrasound...
ABSTRACT Background and Aims Large‐bore femoral access is commonly required in transfemoral transcatheter aortic valve replacement (TF‐TAVR), but vascular complications remain prevalent, impacting patient outcomes. Various closure devices (VCDs) are used for hemostasis, including the suture‐based Prostar XL, Perclose ProGlide, ProStyle, plug‐based MANTA device. However, comprehensive comparative evidence on these VCDs, particularly single strategies, lacking. Methods A systematic review...
ABSTRACT Background Left atrial appendage occlusion (LAAO) is an established therapy for stroke prevention in non‐valvular fibrillation (NVAF), but outcomes Hispanic populations remain underexplored. Objective The objective of our study was to evaluate the inpatient patients undergoing LAAO as compared non‐Hispanic white patients. Methods We conducted a retrospective cohort using National Inpatient Sample (NIS). From 157 434 hospitalizations identified, 133 517 were and 6814 Hispanic/Latino....
The aim of this study was to compare 1-year outcomes for patients with femoropopliteal in-stent restenosis using directional atherectomy guided by intravascular ultrasound (IVUS) versus angiography.This a retrospective analysis treated IVUS-guided angiography from single center between March 2012 and February 2016. Clinically driven target lesion revascularization the primary endpoint evaluated through medical chart review as well phone call follow up.Directional IVUS reduces clinically restenosis.
BackgroundIn-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is higher those COVID-19 than without COVID-19. The factors that predispose to this rate and their relative contribution are poorly understood. This study developed a risk score inclusive of clinical variables predict in-hospital STEMI.MethodsBaseline demographic, clinical, procedural data from the North American Myocardial Infarction registry were extracted. Univariable logistic regression...
The use of the HeartMate 3 (HM3) left ventricular assist device (LVAD) is expanding. Despite being associated with lower rates adverse events and increased survival, outflow graft obstruction (OGO) has been reported in patients HM3. incidence best management this serious complication remain unclear.We describe six cases HM3 OGO occurring five our institutional cohort. Four underwent computed tomography angiography two percutaneous was directly performed to confirm diagnosis. In four cases,...
Abstract Background Multiple interventions, including catheter‐directed therapy (CDT), systemic thrombolysis (ST), surgical embolectomy (SE), and therapeutic anticoagulation (AC) have been used to treat intermediate high‐risk pulmonary embolism (PE), but the most effective safest treatment remains unclear. Our study aimed investigate efficacy safety outcomes of each intervention. Methods We queried PubMed EMBASE in January 2023 performed a network meta‐analysis observational studies...
The treatment of severe aortic stenosis (SAS) has evolved rapidly with the advent minimally invasive structural heart interventions. Transcatheter valve replacement allowed patients to undergo definitive SAS achieving faster recovery rates compared surgery. Not infrequently, are admitted/diagnosed after a fall associated hip fracture (HFx). While urgent orthopedic surgery is key reduce disability and mortality, untreated increases perioperative risk precludes physical recovery. There no...